SE8404869D0 - Antidepressant 1,2,4-triazolone compounds - Google Patents

Antidepressant 1,2,4-triazolone compounds

Info

Publication number
SE8404869D0
SE8404869D0 SE8404869A SE8404869A SE8404869D0 SE 8404869 D0 SE8404869 D0 SE 8404869D0 SE 8404869 A SE8404869 A SE 8404869A SE 8404869 A SE8404869 A SE 8404869A SE 8404869 D0 SE8404869 D0 SE 8404869D0
Authority
SE
Sweden
Prior art keywords
antidepressant
triazolone compounds
compounds
triazolone
phenoxyalkyl
Prior art date
Application number
SE8404869A
Other languages
English (en)
Other versions
SE465928B (sv
SE8404869L (sv
Inventor
R E Gammans
D W Smith
J P Yevich
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24145128&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SE8404869(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of SE8404869D0 publication Critical patent/SE8404869D0/sv
Publication of SE8404869L publication Critical patent/SE8404869L/sv
Publication of SE465928B publication Critical patent/SE465928B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C243/00—Compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D249/12—Oxygen or sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
SE8404869A 1983-09-30 1984-09-28 1,2,4-triazolonfoereningar med antidepressiv aktivitet, foerfarande foer framstaellning av dessa och en farmaceutisk komposition SE465928B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/538,027 US4613600A (en) 1983-09-30 1983-09-30 Antidepressant 1,2,4-triazolone compounds

Publications (3)

Publication Number Publication Date
SE8404869D0 true SE8404869D0 (sv) 1984-09-28
SE8404869L SE8404869L (sv) 1985-03-31
SE465928B SE465928B (sv) 1991-11-18

Family

ID=24145128

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8404869A SE465928B (sv) 1983-09-30 1984-09-28 1,2,4-triazolonfoereningar med antidepressiv aktivitet, foerfarande foer framstaellning av dessa och en farmaceutisk komposition

Country Status (25)

Country Link
US (1) US4613600A (sv)
JP (1) JPS60100560A (sv)
KR (1) KR880002624B1 (sv)
AT (1) AT387963B (sv)
AU (1) AU561460B2 (sv)
BE (1) BE900714A (sv)
CA (1) CA1237723A (sv)
CH (1) CH661924A5 (sv)
CY (1) CY1541A (sv)
DE (1) DE3435745C2 (sv)
DK (1) DK169546B1 (sv)
ES (1) ES536286A0 (sv)
FI (1) FI83310C (sv)
FR (1) FR2552759B1 (sv)
GB (1) GB2147297B (sv)
GR (1) GR80475B (sv)
HK (1) HK37391A (sv)
IE (1) IE58084B1 (sv)
IT (1) IT1178522B (sv)
LU (1) LU85561A1 (sv)
MY (1) MY102123A (sv)
NL (1) NL8402946A (sv)
SE (1) SE465928B (sv)
YU (1) YU45667B (sv)
ZA (1) ZA847589B (sv)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4487773A (en) * 1981-03-16 1984-12-11 Mead Johnson & Company 1,2,4-Triazol-3-one antidepressants
YU44721B (en) * 1983-11-30 1990-12-31 Bristol Myers Co Process for obtaining 4-(2-phenoxyethyl)-1,2,4-triazolone
CA1331757C (en) * 1988-02-29 1994-08-30 Janssen Pharmaceutica Naamloze Vennootschap 5-lipoxygenase inhibiting 4-(4-phenyl-1-piperazinyl)phenols
US5504086A (en) * 1989-10-17 1996-04-02 Ellinwood, Jr.; Everett H. Intraoral dosing method of administering trifluorobenzodiazepines, propoxyphene, and nefazodone
US5256664A (en) * 1992-04-28 1993-10-26 Bristol-Myers Squibb Company Antidepressant 3-halophenylpiperazinylpropyl derivatives of substituted triazolones and triazoldiones
DE4425144A1 (de) * 1994-07-15 1996-01-18 Basf Ag Triazolverbindungen und deren Verwendung
US6403593B1 (en) 1995-07-14 2002-06-11 Abbott Laboratories Triazole compounds and the use thereof
DE19728996A1 (de) 1997-07-07 1999-01-14 Basf Ag Triazolverbindungen und deren Verwendung
US6586437B2 (en) 1999-04-09 2003-07-01 Sepracor Inc. (S)-hydroxynefazodone antipsychotic therapy
US6469008B2 (en) 1999-04-09 2002-10-22 Sepracor Inc. (R)-hydroxynefazodone antipsychotic therapy
AU4215400A (en) * 1999-04-09 2000-11-14 Sepracor, Inc. S-hydroxynefazodone
CA2369732A1 (en) 1999-04-09 2000-10-19 Sepracor Inc. R-hydroxynefazodone
EP1554572B1 (en) 2001-07-25 2009-10-14 Raptor Pharmaceutical Inc. Compositions and methods for modulating blood-brain barrier transport
EP1737473A4 (en) * 2004-04-19 2009-08-26 Noven Therapeutics Llc COMBINATIONS OF LITHIUM AND USES THEREOF
CN101287411B (zh) 2005-04-28 2013-03-06 普罗秋斯生物医学公司 药物信息系统及其用途
CA2663377A1 (en) 2006-09-18 2008-03-27 Raptor Pharmaceutical Inc. Treatment of liver disorders by administration of receptor-associated protein (rap)-conjugates
WO2009111031A2 (en) * 2008-03-04 2009-09-11 Intra-Cellular Therapies, Inc. Methods of treating vasomotor symptoms
NZ594310A (en) 2009-02-20 2014-02-28 To Bbb Holding B V Glutathione-based drug delivery system
MX2011011833A (es) 2009-05-06 2012-01-27 Lab Skin Care Inc Composiciones de administración dérmica que comprenden complejos de partículas de fosfato de calcio-agente activo y métodos para utilizar las mismas.
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
WO2012072665A1 (en) 2010-11-30 2012-06-07 Pharmaneuroboost N.V. Compositions comprising pipamperone and serotonin antagonist reuptake inhibitors
AU2012304407A1 (en) * 2011-09-09 2014-04-24 Children's Hospital & Research Center Oakland Topical itraconazole formulations and uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1066857B (it) * 1965-12-15 1985-03-12 Acraf Derivati della s ipiazolo 4.3 a piridina e processi per la loro preparazione
IT1052119B (it) * 1972-10-16 1981-06-20 Sigma Tau Ind Farmaceuti Derivati del triazolinone e procedimento per la loro preparazione
US4338317A (en) * 1981-03-16 1982-07-06 Mead Johnson & Company Phenoxyethyl-1,2,4,-triazol-3-one antidepressants

Also Published As

Publication number Publication date
CY1541A (en) 1991-03-22
IT1178522B (it) 1987-09-09
GB8424535D0 (en) 1984-11-07
YU45667B (sh) 1992-07-20
DE3435745C2 (de) 1994-11-03
HK37391A (en) 1991-05-24
FI843779A0 (fi) 1984-09-26
DK169546B1 (da) 1994-11-28
US4613600A (en) 1986-09-23
IT8422922A0 (it) 1984-09-28
IE58084B1 (en) 1993-06-30
JPS60100560A (ja) 1985-06-04
AU561460B2 (en) 1987-05-07
FI83310C (sv) 1991-06-25
SE465928B (sv) 1991-11-18
ES8601966A1 (es) 1985-11-16
ES536286A0 (es) 1985-11-16
KR850002270A (ko) 1985-05-10
AT387963B (de) 1989-04-10
ZA847589B (en) 1985-05-29
JPH0542435B2 (sv) 1993-06-28
YU172184A (en) 1986-10-31
KR880002624B1 (ko) 1988-12-07
DK468284A (da) 1985-03-31
SE8404869L (sv) 1985-03-31
MY102123A (en) 1992-03-31
DE3435745A1 (de) 1985-04-11
FI843779L (fi) 1985-03-31
GB2147297A (en) 1985-05-09
FR2552759A1 (fr) 1985-04-05
AU3364884A (en) 1985-04-04
IE842476L (en) 1985-03-30
BE900714A (fr) 1985-03-28
FI83310B (fi) 1991-03-15
ATA310884A (de) 1988-09-15
LU85561A1 (fr) 1985-06-04
CA1237723A (en) 1988-06-07
FR2552759B1 (fr) 1988-10-07
GB2147297B (en) 1987-04-15
CH661924A5 (de) 1987-08-31
NL8402946A (nl) 1985-04-16
GR80475B (en) 1985-01-31
DK468284D0 (da) 1984-09-28

Similar Documents

Publication Publication Date Title
SE8404869D0 (sv) Antidepressant 1,2,4-triazolone compounds
DK356285A (da) 4-(4-(dimethylamino)-1-(4'-fluorphenyl)-1-hydroxybutyl)-3-(hydroxymethyl)-benzonitril, syreadditionssalte deraf, og fremgangsmaade til fremstilling af disse forbindelser
CO4940465A1 (es) Sal mesilato trihidrato de 5-(2-(4-(1,2-benzoisotiazol-3- il)-1-piperazinil)etil)-6-cloro-1,3-dihidro-2h-indol-2-ona
CO4940466A1 (es) Sales metanosulfonato de 5-(2-(4-(1,2-benzoisotiazol-3-il)- 1-piperazinil)etil)-6-cloro-1,3-dihidro-2h-indol-2-ona dihidratadas
NL7904528A (nl) Nieuwe n-aryloxazolidinonen, oxazolidinethionen, pyrro- lidinonen, pyrrolidinen en thiazolidinonen.
DE60128457D1 (de) 1,5-DISUBSTITUIERTE 3,4-DIHYDRO-1H-4,5-DöPYRIMIDIN-2-ON-VERBINDUNGEN UND IHRE VERWENDUNG IN DER BEHANDLUNG VON DURCH CSBP/P38 KINASE BEEINFLUSSTEN KRANKHEITEN
TR200000014T2 (tr) Yeni ikameli imidazol bileşimleri.
NO20000521D0 (no) 1-(N-fenylaminoalkyl)-piperazin derivater substituert i posisjon 2 på fenylringen
SE8600174D0 (sv) Nytt forfarande for framstellning av n-(2-pyrimidinyl)-piperazinylalkylazaspiroalkandioner
PT77735A (fr) Procede de preparation de derives de benzoxazolinone
CY1106993T1 (el) Παραγωγα αζολινης
ATE240321T1 (de) 4- (thien-3-yl)methyl) imidazolderivate mit alpha2-adrenoceptor agonistischer aktivität
DE69106199D1 (de) Heterocyclische Acetonitrile und ihre Verwendung als Fungizide.
FI821739A0 (fi) 1-(3-halogen-2-pyridinyl)piperazin
KR960016716A (ko) 테트라졸리논
ATE266026T1 (de) Benzofurancarboxamide und deren therapeutische verwendung
DE58903912D1 (de) Verwendung von 2-substituierten ethansulfonverbindungen als galvanotechnische hilfsstoffe.
ES532241A0 (es) Un procedimiento para la obtencion de benzoil-ureas.
ATE235450T1 (de) 2-indanmethanolderivate und ihre verwendung als riechstoffe
ES2157318T3 (es) Derivados de difeniloxazolina.
ATE49881T1 (de) Sebosuppressive kosmetische mittel, enthaltend alkoxyaryl-alkanole.
ATE15894T1 (de) Heterocyclische derivate von amidoxinen, ihre herstellung und therapeutische verwendung.
DE59101901D1 (de) Neue 3-substituierte Pyridinmethanole und diese enthaltende Fungizide.
ATE207481T1 (de) Kristallformen von 1-(5-methansulfonamidoindolyl- 2-carbonyl)-4-(3-(1-methylethylamino)-2- pyridinyl) piperazin
DK0812842T3 (da) Fremgangsmåde til fremstilling af 5-(alkoxymethyl)-2,3-pyridindicarboximidforbindelser

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8404869-3

Format of ref document f/p: F

NUG Patent has lapsed